Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Operational immune tolerance towards transplanted allogeneic pancreatic islets in mice and a non-human primate.

Abdulreda MH, Berman DM, Shishido A, Martin C, Hossameldin M, Tschiggfrie A, Hernandez LF, Hernandez A, Ricordi C, Parel JM, Jankowska-Gan E, Burlingham WJ, Arrieta-Quintero EA, Perez VL, Kenyon NS, Berggren PO.

Diabetologia. 2019 May;62(5):811-821. doi: 10.1007/s00125-019-4814-4. Epub 2019 Jan 31.

PMID:
30701283
2.

Leukocyte-Associated Ig-like Receptor 1 Inhibits Th1 Responses but Is Required for Natural and Induced Monocyte-Dependent Th17 Responses.

Agashe VV, Jankowska-Gan E, Keller M, Sullivan JA, Haynes LD, Kernien JF, Torrealba JR, Roenneburg D, Dart M, Colonna M, Wilkes DS, Burlingham WJ.

J Immunol. 2018 Jul 15;201(2):772-781. doi: 10.4049/jimmunol.1701753. Epub 2018 Jun 8.

3.

Modification of host dendritic cells by microchimerism-derived extracellular vesicles generates split tolerance.

Bracamonte-Baran W, Florentin J, Zhou Y, Jankowska-Gan E, Haynes WJ, Zhong W, Brennan TV, Dutta P, Claas FH, van Rood JJ, Burlingham WJ.

Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1099-1104. doi: 10.1073/pnas.1618364114. Epub 2017 Jan 17.

4.

Th17 Responses to Collagen Type V, kα1-Tubulin, and Vimentin Are Present Early in Human Development and Persist Throughout Life.

Sullivan JA, Jankowska-Gan E, Hegde S, Pestrak MA, Agashe VV, Park AC, Brown ME, Kernien JF, Wilkes DS, Kaufman DB, Greenspan DS, Burlingham WJ.

Am J Transplant. 2017 Apr;17(4):944-956. doi: 10.1111/ajt.14097. Epub 2016 Dec 19.

5.

Kinetics of Alloantigen-Specific Regulatory CD4 T Cell Development and Tissue Distribution After Donor-Specific Transfusion and Costimulatory Blockade.

Tomita Y, Satomi M, Bracamonte-Baran W, Jankowska Gan E, Workman AS, Workman CJ, Vignali DA, Burlingham WJ.

Transplant Direct. 2016 Apr 21;2(5):e73. doi: 10.1097/TXD.0000000000000580. eCollection 2016 May.

6.

Patterns of Immune Regulation in Rhesus Macaque and Human Families.

Burlingham WJ, Jankowska-Gan E, Kempton S, Haynes L, Kaufman DB.

Transplant Direct. 2015 Jul 23;1(6):e20. doi: 10.1097/TXD.0000000000000530. eCollection 2015 Jul.

7.

Mucosal Administration of Collagen V Ameliorates the Atherosclerotic Plaque Burden by Inducing Interleukin 35-dependent Tolerance.

Park AC, Huang G, Jankowska-Gan E, Massoudi D, Kernien JF, Vignali DA, Sullivan JA, Wilkes DS, Burlingham WJ, Greenspan DS.

J Biol Chem. 2016 Feb 12;291(7):3359-70. doi: 10.1074/jbc.M115.681882. Epub 2015 Dec 31.

8.

Microchimerism and regulation in living related kidney transplant families.

Haynes WJ, Jankowska-Gan E, Haynes L, Burlingham WJ.

Chimerism. 2014;5(3-4):80-5. doi: 10.1080/19381956.2015.1111974.

9.

Differential requirement for P2X7R function in IL-17 dependent vs. IL-17 independent cellular immune responses.

Sullivan JA, Jankowska-Gan E, Shi L, Roenneburg D, Hegde S, Greenspan DS, Wilkes DS, Denlinger LC, Burlingham WJ.

Am J Transplant. 2014 Jul;14(7):1512-22. doi: 10.1111/ajt.12741. Epub 2014 May 27.

10.

HY immune tolerance is common in women without male offspring.

Dierselhuis MP, Jankowska-Gan E, Blokland E, Pool J, Burlingham WJ, van Halteren AG, Goulmy E.

PLoS One. 2014 Mar 19;9(3):e91274. doi: 10.1371/journal.pone.0091274. eCollection 2014.

11.

Epitope analysis of the collagen type V-specific T cell response in lung transplantation reveals an HLA-DRB1*15 bias in both recipient and donor.

Keller MR, Haynes LD, Jankowska-Gan E, Sullivan JA, Agashe VV, Burlingham SR, Burlingham WJ.

PLoS One. 2013 Nov 12;8(11):e79601. doi: 10.1371/journal.pone.0079601. eCollection 2013.

12.

Trans-vivo delayed type hypersensitivity assay for antigen specific regulation.

Jankowska-Gan E, Hegde S, Burlingham WJ.

J Vis Exp. 2013 May 2;(75):e4454. doi: 10.3791/4454.

13.

Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade.

Olson BM, Jankowska-Gan E, Becker JT, Vignali DA, Burlingham WJ, McNeel DG.

J Immunol. 2012 Dec 15;189(12):5590-601. doi: 10.4049/jimmunol.1201744. Epub 2012 Nov 14.

14.

Pretransplant immune regulation predicts allograft outcome: bidirectional regulation correlates with excellent renal transplant function in living-related donor-recipient pairs.

Jankowska-Gan E, Sheka A, Sollinger HW, Pirsch JD, Hofmann RM, Haynes LD, Armbrust MJ, Mezrich JD, Burlingham WJ.

Transplantation. 2012 Feb 15;93(3):283-90. doi: 10.1097/TP.0b013e31823e46a0.

15.

Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients.

Haynes LD, Jankowska-Gan E, Sheka A, Keller MR, Hernandez-Fuentes MP, Lechler RI, Seyfert-Margolis V, Turka LA, Newell KA, Burlingham WJ.

Am J Transplant. 2012 Mar;12(3):640-8. doi: 10.1111/j.1600-6143.2011.03869.x. Epub 2011 Dec 7.

16.

A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas.

Ma SD, Hegde S, Young KH, Sullivan R, Rajesh D, Zhou Y, Jankowska-Gan E, Burlingham WJ, Sun X, Gulley ML, Tang W, Gumperz JE, Kenney SC.

J Virol. 2011 Jan;85(1):165-77. doi: 10.1128/JVI.01512-10. Epub 2010 Oct 27.

17.

Interleukin-17-dependent autoimmunity to collagen type V in atherosclerosis.

Dart ML, Jankowska-Gan E, Huang G, Roenneburg DA, Keller MR, Torrealba JR, Rhoads A, Kim B, Bobadilla JL, Haynes LD, Wilkes DS, Burlingham WJ, Greenspan DS.

Circ Res. 2010 Oct 29;107(9):1106-16. doi: 10.1161/CIRCRESAHA.110.221069. Epub 2010 Sep 2.

18.

HLA-A, -B, and -DR zero-mismatched kidneys shipped to the University of Wisconsin, Madison, 1993-2006: superior graft survival despite longer preservation time.

Burlingham WJ, Muñoz del Rio A, Lorentzen D, Sollinger HW, Pirsch JD, Jankowska-Gan E, D'Alessandro A.

Transplantation. 2010 Aug 15;90(3):312-8. doi: 10.1097/TP.0b013e3181e49b9f.

19.

Reflux-induced collagen type v sensitization: potential mediator of bronchiolitis obliterans syndrome.

Bobadilla JL, Jankowska-Gan E, Xu Q, Haynes LD, Munoz del Rio A, Meyer K, Greenspan DS, De Oliveira N, Burlingham WJ, Maloney JD.

Chest. 2010 Aug;138(2):363-70. doi: 10.1378/chest.09-2610. Epub 2010 Apr 23.

20.

Th1 and Th17 immunocompetence in humanized NOD/SCID/IL2rgammanull mice.

Rajesh D, Zhou Y, Jankowska-Gan E, Roenneburg DA, Dart ML, Torrealba J, Burlingham WJ.

Hum Immunol. 2010 Jun;71(6):551-9. doi: 10.1016/j.humimm.2010.02.019. Epub 2010 Mar 26.

21.

Transfer of tolerance to collagen type V suppresses T-helper-cell-17 lymphocyte-mediated acute lung transplant rejection.

Braun RK, Molitor-Dart M, Wigfield C, Xiang Z, Fain SB, Jankowska-Gan E, Seroogy CM, Burlingham WJ, Wilkes DS, Brand DD, Torrealba J, Love RB.

Transplantation. 2009 Dec 27;88(12):1341-8. doi: 10.1097/TP.0b013e3181bcde7b.

22.

Successful reduction of immunosuppression in older renal transplant recipients who exhibit donor-specific regulation.

Jankowska-Gan E, Sollinger HW, Pirsch JD, Cai J, Pascual J, Haynes LD, Munoz del Rio A, Burlingham WJ.

Transplantation. 2009 Aug 27;88(4):533-41. doi: 10.1097/TP.0b013e3181b0f92f.

23.

Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members.

van Halteren AG, Jankowska-Gan E, Joosten A, Blokland E, Pool J, Brand A, Burlingham WJ, Goulmy E.

Blood. 2009 Sep 10;114(11):2263-72. doi: 10.1182/blood-2009-01-200410. Epub 2009 Jun 8.

24.

Human NKT cells promote monocyte differentiation into suppressive myeloid antigen-presenting cells.

Hegde S, Jankowska-Gan E, Roenneburg DA, Torrealba J, Burlingham WJ, Gumperz JE.

J Leukoc Biol. 2009 Oct;86(4):757-68. doi: 10.1189/jlb.0209059.

25.

Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring.

Knechtle SJ, Pascual J, Bloom DD, Torrealba JR, Jankowska-Gan E, Burlingham WJ, Kwun J, Colvin RB, Seyfert-Margolis V, Bourcier K, Sollinger HW.

Am J Transplant. 2009 May;9(5):1087-98. doi: 10.1111/j.1600-6143.2009.02581.x. Epub 2009 Mar 16.

26.

Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation.

Bobadilla JL, Love RB, Jankowska-Gan E, Xu Q, Haynes LD, Braun RK, Hayney MS, Munoz del Rio A, Meyer K, Greenspan DS, Torrealba J, Heidler KM, Cummings OW, Iwata T, Brand D, Presson R, Burlingham WJ, Wilkes DS.

Am J Respir Crit Care Med. 2008 Mar 15;177(6):660-8. doi: 10.1164/rccm.200612-1901OC. Epub 2008 Jan 3.

27.

IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants.

Burlingham WJ, Love RB, Jankowska-Gan E, Haynes LD, Xu Q, Bobadilla JL, Meyer KC, Hayney MS, Braun RK, Greenspan DS, Gopalakrishnan B, Cai J, Brand DD, Yoshida S, Cummings OW, Wilkes DS.

J Clin Invest. 2007 Nov;117(11):3498-506.

28.
29.

T-cell responses to hepatitis B surface antigen in lung transplant recipients.

Hayney MS, Wiegert NA, Pelsue FL, Fohl RM, Jankowska-Gan E, Love RB, Burlingham WJ.

Pharmacotherapy. 2007 Sep;27(9):1248-52.

PMID:
17723078
30.

Human CD4+CD25low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance.

Xu Q, Lee J, Jankowska-Gan E, Schultz J, Roenneburg DA, Haynes LD, Kusaka S, Sollinger HW, Knechtle SJ, VanBuskirk AM, Torrealba JR, Burlingham WJ.

J Immunol. 2007 Mar 15;178(6):3983-95. Erratum in: J Immunol. 2007 Jun 1;178(11):7488. Roennburg, Drew A [corrected to Roenneburg, Drew A].

31.
32.

Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates.

Torrealba JR, Katayama M, Fechner JH Jr, Jankowska-Gan E, Kusaka S, Xu Q, Schultz JM, Oberley TD, Hu H, Hamawy MM, Jonker M, Wubben J, Doxiadis G, Bontrop R, Burlingham WJ, Knechtle SJ.

J Immunol. 2004 May 1;172(9):5753-64.

33.

Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance.

Cai J, Lee J, Jankowska-Gan E, Derks R, Pool J, Mutis T, Goulmy E, Burlingham WJ.

J Exp Med. 2004 Apr 5;199(7):1017-23.

34.

HLA class I noninherited maternal antigens in cord blood and breast milk.

Molitor ML, Haynes LD, Jankowska-Gan E, Mulder A, Burlingham WJ.

Hum Immunol. 2004 Mar;65(3):231-9.

PMID:
15041161
35.

Immune regulation and graft survival in kidney transplant recipients are both enhanced by human leukocyte antigen matching.

Rodriguez DS, Jankowska-Gan E, Haynes LD, Leverson G, Munoz A, Heisey D, Sollinger HW, Burlingham WJ.

Am J Transplant. 2004 Apr;4(4):537-43.

36.

Tolerance to noninherited maternal MHC antigens in mice.

Andrassy J, Kusaka S, Jankowska-Gan E, Torrealba JR, Haynes LD, Marthaler BR, Tam RC, Illigens BM, Anosova N, Benichou G, Burlingham WJ.

J Immunol. 2003 Nov 15;171(10):5554-61.

37.

Human liver allograft acceptance and the "tolerance assay". II. Donor HLA-A, -B but not DR antigens are able to trigger regulation of DTH.

Jankowska-Gan E, Rhein T, Haynes LD, Geissler F, Mulder A, Kalayoglu M, Sollinger H, Burlingham WJ.

Hum Immunol. 2002 Oct;63(10):862-70.

PMID:
12368038
38.

Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients.

Thomson AW, Mazariegos GV, Reyes J, Donnenberg VS, Donnenberg AD, Bentlejewski C, Zahorchak AF, O'Connell PJ, Fung JJ, Jankowska-Gan E, Burlingham WJ, Heeger PS, Zeevi A.

Transplantation. 2001 Oct 27;72(8 Suppl):S13-22. Review.

PMID:
11888150
39.

Human liver allograft acceptance and the "tolerance assay": in vitro anti-donor T cell assays show hyporeactivity to donor cells, but unlike DTH, fail to detect linked suppression.

Geissler F, Jankowska-Gan E, DeVito-Haynes LD, Rhein T, Kalayoglu M, Sollinger HW, Burlingham WJ.

Transplantation. 2001 Aug 27;72(4):571-80.

PMID:
11544414
40.

Immunoregulation in liver transplant recipients: possible evidence of tolerance by DTH assay.

Geissler F, Jankowska-Gan E, Sollinger H, Kalayoglu M, VanBuskirk AM, Orosz CG, Burlingham W.

Transplant Proc. 2001 Feb-Mar;33(1-2):1377. No abstract available.

PMID:
11267335
41.

Cell-mediated immunity to collagen V in lung transplant recipients: correlation with collagen V release into BAL fluid.

Wilkes DS, Heidler KM, Yasufuku K, Devito-Haynes L, Jankowska-Gan E, Meyer KC, Love RB, Burlingham WJ.

J Heart Lung Transplant. 2001 Feb;20(2):167. No abstract available.

PMID:
11250258
42.

Loss of tolerance to a maternal kidney transplant is selective for HLA class II: evidence from trans-vivo DTH and alloantibody analysis.

Burlingham WJ, Jankowska-Gan E, VanBuskirk A, Orosz CG, Lee JH, Kusaka S.

Hum Immunol. 2000 Dec;61(12):1395-402.

PMID:
11163098
43.

Soluble donor HLA class I and beta 2m-free heavy chain in serum of lung transplant recipients: steady-state levels and increases in patients with recurrent CMV infection, acute rejection episodes, and poor outcome.

DeVito-Haynes LD, Jankowska-Gan E, Meyer KC, Cornwell RD, Zeevi A, Griffith B, Dauber J, Iacono A, Burlingham WJ, Love RB.

Hum Immunol. 2000 Dec;61(12):1370-82.

PMID:
11163095
44.

Human allograft acceptance is associated with immune regulation.

VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, Chin T, Kusaka S, Geissler F, Pelletier RP, Orosz CG.

J Clin Invest. 2000 Jul;106(1):145-55.

45.

Clonotype analysis of human alloreactive T cells: a novel approach to studying peripheral tolerance in a transplant recipient.

Kusaka S, Grailer AP, Fechner JH Jr, Jankowska-Gan E, Oberley T, Sollinger HW, Burlingham WJ.

J Immunol. 2000 Feb 15;164(4):2240-7.

46.

HLA (A*0201) mimicry by anti-idiotypic monoclonal antibodies.

Burlingham WJ, Jankowska-Gan E, DeVito-Haynes L, Fechner JH Jr, Hogan KT, Claas FH, Mulder A, Wang X, Ferrone S.

J Immunol. 1998 Dec 15;161(12):6705-14.

47.

Soluble HLA class I in epithelial lining fluid of lung transplants: associations with graft outcome.

DeVito-Haynes LD, Jankowska-Gan E, Heisey DM, Cornwell RD, Meyer KC, Love RB, Burlingham WJ.

Hum Immunol. 1997 Feb;52(2):95-108.

PMID:
9077558
48.

Donor-derived human leukocyte antigen class I proteins in the serum of heart transplant recipients.

DeVito-Haynes LD, Jankowska-Gan E, Heisey D, Jutte NH, Balk AH, Weimar W, Claas FH, Warner TF, Mentzer RM, Love RB, Burlingham WJ.

J Heart Lung Transplant. 1996 Oct;15(10):1012-26.

PMID:
8913919
49.

Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I.

DeVito-Haynes LD, Jankowska-Gan E, Sollinger HW, Knechtle SJ, Burlingham WJ.

Hum Immunol. 1994 Jul;40(3):191-201.

PMID:
7960963
50.

Epitope fine specificity of human anti-HLA-A2 antibodies. Identification of four epitopes including a haptenlike epitope on HLA-A2 at lysine 127.

De Vito LD, Mason BP, Jankowska-Gan E, Hogan KT, Guo JW, Lutz CT, Sollinger HW, Burlingham WJ.

Hum Immunol. 1993 Jul;37(3):165-77.

PMID:
7503972

Supplemental Content

Loading ...
Support Center